- Home
- ATXI vs UOKA Comparison
ATXI vs UOKA Comparison
Compare ATXI & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXI
- UOKA
- Stock Information
- Founded
- ATXI 2015
- UOKA 2002
- Country
- ATXI United States
- UOKA United Kingdom
- Employees
- ATXI N/A
- UOKA N/A
- Industry
- ATXI Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- ATXI Health Care
- UOKA
- Exchange
- ATXI Nasdaq
- UOKA NYSE
- Market Cap
- ATXI 3.0M
- UOKA 2.8M
- IPO Year
- ATXI 2017
- UOKA N/A
- Fundamental
- Price
- ATXI $1.85
- UOKA $0.18
- Analyst Decision
- ATXI
- UOKA
- Analyst Count
- ATXI 0
- UOKA 0
- Target Price
- ATXI N/A
- UOKA N/A
- AVG Volume (30 Days)
- ATXI 61.4K
- UOKA 2.1M
- Earning Date
- ATXI 11-14-2024
- UOKA 02-16-2025
- Dividend Yield
- ATXI N/A
- UOKA N/A
- EPS Growth
- ATXI N/A
- UOKA N/A
- EPS
- ATXI N/A
- UOKA N/A
- Revenue
- ATXI N/A
- UOKA $114,849.00
- Revenue This Year
- ATXI N/A
- UOKA N/A
- Revenue Next Year
- ATXI N/A
- UOKA N/A
- P/E Ratio
- ATXI N/A
- UOKA N/A
- Revenue Growth
- ATXI N/A
- UOKA 289.97
- 52 Week Low
- ATXI $1.60
- UOKA $0.14
- 52 Week High
- ATXI $15.00
- UOKA $1.90
- Technical
- Relative Strength Index (RSI)
- ATXI 47.67
- UOKA N/A
- Support Level
- ATXI $1.72
- UOKA N/A
- Resistance Level
- ATXI $2.04
- UOKA N/A
- Average True Range (ATR)
- ATXI 0.19
- UOKA 0.00
- MACD
- ATXI -0.00
- UOKA 0.00
- Stochastic Oscillator
- ATXI 33.39
- UOKA 0.00
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.